The position is a full-time position (38,5 h/w) and is project-related funded until the 31st of December 2021 with the option of extension. The salary corresponds to
level 13 TV-L.
It has been recently shown that chronic kidney disease (CKD) patients have an increased risk for cardiovascular disease (CVD), although the precise underlying mechanisms remain elusive.
Candidates will perform research to explore the contribution of a novel mechanism of immune-lipid crosstalk, which might explain at least partly the observed increased CVD risk in CKD-patients. Hereby, the focus will be to investigate the interference of high-density lipoproteins (HDL) and other lipids with the chemokine-receptor signaling and its functional consequences.
Candidates will be working with a wide variety of both in-vitro and in-vivo (mouse) models. The working language of the group is English.
The candidate should hold a PhD in Biology or Biomedical Sciences.
The RWTH Aachen University is certified as a family-friendly university and offers a dual career program for partner hiring. We particularly welcome and encourage applications from women, disabled people and ethnic minority groups, recognizing they are underrepresented across RWTH Aachen University. The principles of fair and open competition apply and appointments will be made on merit.
Interested candidates should send a brief motivation letter, CV and the names of two references (code-no: GB-P-16536 by April 26th, 2019) to
[email protected].
